Institute for Advanced Study, Shenzhen University, Shenzhen, Guangdong, China.
Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, Guangdong, China.
J Biol Inorg Chem. 2019 Oct;24(7):1023-1033. doi: 10.1007/s00775-019-01699-6. Epub 2019 Sep 10.
In the present work, we performed Density Functional Theory calculations to explore the bioactivation mechanism of thiophene-containing molecules mediated by P450s. For this purpose, relatively large size compounds, 2,5-diaminothiophene derivatives were selected particularly for this investigation. Here we found the successive regio-selectivity triggered by conformational turn played a significant role in the occurrence of bioactivation. 2,5-Diaminothiophene was oxidized to a 2,5-diimine thiophene-reactive intermediate by Compound I (Cpd I) through successive activations of two N-H bonds (H3-N11 and H1-N6). This reaction exhibited three special characteristics: (1) self-controlled regio-selectivity during the oxidation process. There was a large scale of conformational turn in the abstraction of the first H atom which triggers the selection of the second H for abstraction. (2) Proton-shuttle mechanism. In high spin (HS) state, proton-shuttle mechanism was observed for the abstraction of the second H atom. (3) Spin-selective manner. In protein environment, the energy barrier in HS state was much lower than that in low spin state. The novel proposed bioactivation mechanism of 2,5-diaminothiophene compounds can help us in rational design of thiophene-contained drugs avoiding the occurrence of bioactivation.
在本工作中,我们通过密度泛函理论计算来探索含噻吩分子的生物活化机制。为此,我们选择了相对较大尺寸的化合物,即 2,5-二氨基噻吩衍生物,特别针对这一研究。在这里,我们发现构象转变引发的连续区域选择性在生物活化的发生中起着重要作用。2,5-二氨基噻吩通过 Cpd I(化合物 I)连续活化两个 N-H 键(H3-N11 和 H1-N6)被氧化为 2,5-二亚胺噻吩反应性中间体。该反应表现出三个特殊特征:(1)在氧化过程中具有自我控制的区域选择性。在第一个 H 原子的提取过程中发生了大规模的构象转变,这触发了第二个 H 原子的提取选择。(2)质子转移机制。在高自旋(HS)状态下,观察到第二个 H 原子提取的质子转移机制。(3)自旋选择性方式。在蛋白质环境中,HS 状态下的能量势垒远低于低自旋状态。2,5-二氨基噻吩化合物的新型生物活化机制可以帮助我们合理设计含噻吩药物,避免生物活化的发生。